Hanmi Pharmaceutical's Countmate targets the vial-based medication packaging market in Canada and the US. Hanmi ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Hanmi Pharmaceutical has launched Countmate, a fully automated vial dispensing machine designed to meet the specific needs of ...

Celltrion’s plan to build a new drug product plant in Incheon's Songdo received approval from local authorities, the ...

A Gold Star Wife of a U.S. Army sergeant was given the keys to a mortgage-free condo to honor his military service on ...

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Through ClinFAST, Selkirk is focused on meeting critical clinical timelines. Selkirk Pharma CEO Colleen Dixon said: “In ...

Quarterly / Interim Statement/Quarter ResultsSCHOTT Pharma records good start into fiscal year and confirms full year outlook 13.02.2025 / 07:00 CET/CESTThe issuer is solely responsible for the ...

SEOUL, South Korea, Feb. 13, 2025 /CNW/ -- Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making ...

Korea initiates biobank project to collect genetic data from 1 million citizens Korea sets ambitious goal to develop precision medicine based on citizen genetic profiles ...

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.